Aluminum Medicinal Ointment Tubes: Alloy, Barrier and GMP Control

Jan 26, 2024

Leave a message

Aluminum ointment tubes are the established primary package for topical pharmaceuticals because the metal body provides an absolute barrier to light, oxygen, water vapour and micro-organisms. Performance depends on alloy purity, wall thickness, lacquer system and the dimensional control of the nozzle and closure.

Tube Construction and Alloy Selection

A collapsible tube consists of a soft metal body, an integral shoulder and nozzle, a sealed base and a closure. The body is drawn or impact extruded from low alloy, high purity aluminium: 1050, 1060, 1070 and 1235 are standard, generally at 99.5 percent purity or higher, because trace elements affect both formability and interaction with the formulation. Wall thickness is typically 0.09 to 0.15 mm, with 0.10 to 0.13 mm the common production range; thinner walls reduce weight but make the tube prone to dents in distribution. Tube diameters normally run from about 11 mm to 40 mm, covering fill volumes from roughly 5 g to 200 g. For single-use or viscous products the nozzle is closed by an integral membrane that the cap pierces before first use. Foil for tube stock is ordered against GB/T 3198 or the EN 546 series, which separate technical conditions, mechanical properties and dimensional tolerances, so that hardness and thickness are contractual.

Barrier Performance and Internal Lacquer Systems

The metal body is an absolute barrier, so the only compatibility risk comes from direct contact between aluminium and the formulation. Acidic or fatty products, and those containing chloride ions or sulphur compounds, can react with bare aluminium. The standard solution is an internal lacquer, normally an epoxy-phenolic or polyester system applied at 6 to 12 micron dry film weight, which also protects the metal from formulation-induced corrosion. Lacquer selection is based on the pH and solvent content of the fill, and continuity is verified electrically on production lines. Coating materials and finished articles must satisfy the applicable regulatory framework: EU 1935/2004 for food contact materials sets an overall migration limit of 10 mg/dm2 or 60 mg/kg, 21 CFR 175.300 covers resinous and polymeric coatings on metal in the United States, and plastic closures or liners are covered by the plastics rules such as EU 10/2011. Adhesion of the lacquer after forming and after filling is checked by tape test methods such as ASTM D3359, and water vapour transmission of laminate or liner materials is measured to ASTM E96.

Dimensional Tolerances and Closure Systems

Dimensional control determines whether a tube runs on an automatic filling line. Key dimensions are the nozzle bore and thread form, the shoulder diameter, the body diameter and the overall length. Wall thickness variation, roundness and camber are quoted to tolerance classes taken from EN 546-3 or an equivalent standard. Closures are normally polypropylene or high density polyethylene caps, with a liner or a plug seal selected for the formulation; tamper evidence is provided by a drop ring or a sealed band. Nozzle membrane thickness and puncture force must be specified together, because a membrane that is too thick is difficult for the patient to pierce and one that is too thin may fail in transit. Tube-to-cap torque, drop testing and internal pressure testing are the routine release checks.

Regulatory and Cleanliness Requirements

Primary packaging materials for medicinal products are produced under a quality management system for packaging materials, and the applicable guidance is ISO 15378, which applies good manufacturing practice principles to printed and unprinted primary packaging. Container performance testing for pharmaceutical containers follows pharmacopoeial methods such as USP 671, and in China drug packaging materials are governed by the YBB series of national packaging material standards. Practical cleanroom controls cover airborne particle counts, residual lubricant and drawing soap on the internal surface, and foil debris. Production areas for tube bodies and lacquering are typically operated at ISO 8 class cleanliness, with tighter control at the nozzle and inside the cap. Batch documentation normally includes alloy certificate, lacquer batch, migration test data and dimensional records.

Frequently Asked Questions

Q: What purity does aluminum ointment tube stock require?
A: Alloys such as 1050, 1060, 1070 and 1235 are used at 99.5 percent purity or higher, so that trace elements do not affect formability or formulation compatibility.

Q: Why do aluminium tubes need an internal lacquer?
A: Acidic, fatty or chloride-containing formulations can react with bare aluminium. A 6 to 12 micron epoxy-phenolic or polyester lacquer isolates the metal and protects both the product and the tube.

Q: What wall thickness is typical for a pharmaceutical ointment tube?
A: Between 0.09 and 0.15 mm, most often 0.10 to 0.13 mm. Thinner walls reduce weight but increase the risk of denting during distribution.

Q: Which regulations apply to tube lacquer and closures?
A: EU 1935/2004 with an overall migration limit of 10 mg/dm2 or 60 mg/kg, 21 CFR 175.300 for coatings on metal in the United States, and EU 10/2011 for plastic caps and liners.

Q: How is lacquer continuity checked in production?
A: Electrically, using a conductivity based enamel-rater check on the finished tube, supported by adhesion testing to ASTM D3359 after forming.

Q: Does an aluminum tube need sterilisation?
A: Ointment products are usually non-sterile, so microbial limits rather than sterility apply. Where a sterile fill is required, the tube and closure system must be validated for the chosen sterilisation method and the lacquer re-qualified afterwards.